Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-21-1345
Abstract: Checkpoint inhibitors (CPIs) have revolutionized the treatment paradigm for advanced solid tumors; however, there remains an opportunity to improve response rates and outcomes. In preclinical models, 4-1BB costimulation synergizes with CPIs targeting the PD-1/PD-L1 axis…
read more here.
Keywords:
patients advanced;
gen1046;
1bb gen1046;
solid tumors ... See more keywords